Aescap invests in high-growth companies dedicated to develop and market highly innovative medical treatments that are de-risked from a technology and finance perspective. Our ability to outperform the market is the result of a focused investment strategy, and the team members being part of the healthcare industry for decades. During this period of over 25 years we have established an extensive network which is typically helpful in our extensive due diligence process. Our investment decisions are based on thorough fundamental analyses and a constant dialogue with management, complemented by an active disciplined buy and sell strategy.
